341 related articles for article (PubMed ID: 26416490)
1. Modifiable factors and cognitive dysfunction in breast cancer survivors: a mixed-method systematic review.
Henneghan A
Support Care Cancer; 2016 Jan; 24(1):481-497. PubMed ID: 26416490
[TBL] [Abstract][Full Text] [Related]
2. Lifestyle factors associated with cognitive functioning in breast cancer survivors.
Hartman SJ; Marinac CR; Natarajan L; Patterson RE
Psychooncology; 2015 Jun; 24(6):669-75. PubMed ID: 25073541
[TBL] [Abstract][Full Text] [Related]
3. Modifiable correlates of perceived cognitive function in breast cancer survivors up to 10 years after chemotherapy completion.
Henneghan A; Stuifbergen A; Becker H; Kesler S; King E
J Cancer Surviv; 2018 Apr; 12(2):224-233. PubMed ID: 29116555
[TBL] [Abstract][Full Text] [Related]
4. The Experience of Cancer-Related Cognitive Impairment Across Common Cancers: Protocol for a Qualitative Systematic Review.
Ibrar M; Rai HK; Main A; McCartney H; Maguire R; Rodriguez MAP
JMIR Res Protoc; 2024 May; 13():e56888. PubMed ID: 38820581
[TBL] [Abstract][Full Text] [Related]
5. Web based survivorship interventions for women with breast cancer: An integrative review.
Post KE; Flanagan J
Eur J Oncol Nurs; 2016 Dec; 25():90-99. PubMed ID: 27865259
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and associated factors of chemotherapy-related cognitive impairment in older breast cancer survivors.
Zhou X; Zhang X; Zhong T; Zhou M; Gao L; Chen L
J Adv Nurs; 2024 Feb; 80(2):484-499. PubMed ID: 37675947
[TBL] [Abstract][Full Text] [Related]
7. Can physical activity help to maintain cognitive functioning and psychosocial well-being among breast cancer patients treated with chemotherapy? A randomised controlled trial: study protocol.
Gokal K; Munir F; Wallis D; Ahmed S; Boiangiu I; Kancherla K
BMC Public Health; 2015 Apr; 15():414. PubMed ID: 25903195
[TBL] [Abstract][Full Text] [Related]
8. Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review.
Howard-Anderson J; Ganz PA; Bower JE; Stanton AL
J Natl Cancer Inst; 2012 Mar; 104(5):386-405. PubMed ID: 22271773
[TBL] [Abstract][Full Text] [Related]
9. Genetic risk factors for cancer-related cognitive impairment: a systematic review.
Buskbjerg CDR; Amidi A; Demontis D; Nissen ER; Zachariae R
Acta Oncol; 2019 May; 58(5):537-547. PubMed ID: 30822178
[No Abstract] [Full Text] [Related]
10. Predictors of distress in female breast cancer survivors: a systematic review.
Syrowatka A; Motulsky A; Kurteva S; Hanley JA; Dixon WG; Meguerditchian AN; Tamblyn R
Breast Cancer Res Treat; 2017 Sep; 165(2):229-245. PubMed ID: 28553684
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy-related cognitive impairment: the breast cancer experience.
Myers JS
Oncol Nurs Forum; 2012 Jan; 39(1):E31-40. PubMed ID: 22201666
[TBL] [Abstract][Full Text] [Related]
12. Cancer-related cognitive impairment in survivors of adolescent and young adult non-central nervous system cancer: A scoping review.
Vizer LM; Mikles SP; Piepmeier AT
Psychooncology; 2022 Aug; 31(8):1275-1285. PubMed ID: 35726379
[TBL] [Abstract][Full Text] [Related]
13. A Pilot Study of a Cognitive-Behavioral Intervention for Breast Cancer Survivors.
Becker H; Henneghan AM; Volker DL; Mikan SQ
Oncol Nurs Forum; 2017 Mar; 44(2):255-264. PubMed ID: 28222075
[TBL] [Abstract][Full Text] [Related]
14. Women's experiences of cancer-related cognitive impairment, its impact on daily life and care received for it following treatment for breast cancer.
Bolton G; Isaacs A
Psychol Health Med; 2018 Dec; 23(10):1261-1274. PubMed ID: 30048158
[TBL] [Abstract][Full Text] [Related]
15. An integrative review of subjective and objective measures of sleep disturbances in breast cancer survivors.
Budhrani PH; Lengacher CA; Kip K; Tofthagen C; Jim H
Clin J Oncol Nurs; 2015 Apr; 19(2):185-91. PubMed ID: 25840384
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal impact of yoga on chemotherapy-related cognitive impairment and quality of life in women with early stage breast cancer: a case series.
Galantino ML; Greene L; Daniels L; Dooley B; Muscatello L; O'Donnell L
Explore (NY); 2012; 8(2):127-35. PubMed ID: 22385567
[TBL] [Abstract][Full Text] [Related]
17. A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy.
Lawrence JA; Griffin L; Balcueva EP; Groteluschen DL; Samuel TA; Lesser GJ; Naughton MJ; Case LD; Shaw EG; Rapp SR
J Cancer Surviv; 2016 Feb; 10(1):176-84. PubMed ID: 26130292
[TBL] [Abstract][Full Text] [Related]
18. Modifiable risk factors for breast cancer recurrence: what can we tell survivors?
Norman SA; Potashnik SL; Galantino ML; De Michele AM; House L; Localio AR
J Womens Health (Larchmt); 2007 Mar; 16(2):177-90. PubMed ID: 17388734
[TBL] [Abstract][Full Text] [Related]
19. A systematic review of rehabilitation programs for cognitive impairment related to breast cancer: Different programs at different times?
Merceur M; Reilly KT; Bonan I; Holé J; Hummel E; Cogné M; Jacquin-Courtois S
Ann Phys Rehabil Med; 2024 Jun; 67(5):101832. PubMed ID: 38537525
[TBL] [Abstract][Full Text] [Related]
20. What causes breast cancer? A systematic review of causal attributions among breast cancer survivors and how these compare to expert-endorsed risk factors.
Dumalaon-Canaria JA; Hutchinson AD; Prichard I; Wilson C
Cancer Causes Control; 2014 Jul; 25(7):771-85. PubMed ID: 24771106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
